1 / 5

Clinical Trials Update June 24 th 2005

Clinical Trials Update June 24 th 2005. Jameson, New Castle. Murtha CC, Johnstown. Our Consortium . AGH. UPMC Hillman. Somerset. Mercy. UPMC McKeesport. RTOG Membership. UPMC McKeesport (February 2005) Mercy Hospital (Previous member) UPMC Murtha (June 2005)

gallagher
Download Presentation

Clinical Trials Update June 24 th 2005

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Trials Update June 24th 2005

  2. Jameson, New Castle Murtha CC, Johnstown Our Consortium AGH UPMC Hillman Somerset Mercy UPMC McKeesport

  3. RTOG Membership • UPMC McKeesport (February 2005) • Mercy Hospital (Previous member) • UPMC Murtha (June 2005) • Somerset Cancer Center (pending) • Jameson Hospital (pending)

  4. The Clinical Trials • High Priority Trials • RTOG 0420: • TMZ/XRT followed by TMZ-CPT11 for GBM • IRB approved 2/05 • Accrued 2 patients • RTOG 0235: • PET pre- & post-treatment for locally advanced NSCLC • Under IRB review, anticipate approval July/August 2005 • RTOG 0214 • PCI for NSCLC after definitive chemoradiotherapy • IRB approved

  5. Clinical Trials (cont…) • NSABP B39/ RTOG 0431 • Whole breast irradiation vs. Partial breast irradiation for early stage breast cancer • Currently under IRB review • CDRP Lung (Wynn) • Amifostine to minimize treatment breaks for NSCLC • Under IRB review; anticipate approval July/August 2005

More Related